STONKWHISPER
← Back to Intel
Insider ActivityJAZZ

Smith Mark Douglas, Director at Jazz Pharmaceuticals plc, sold $267K of JAZZ

Updated Jun 19, 2026
Smith Mark Douglas Director
Jazz Pharmaceuticals plc · $JAZZ
$267K Total Value
1,157 Shares Traded
$230.55 Price / Share
9,680 Shares Owned After
2026-06-17 Filing Date

Transaction Details

InsiderSmith Mark Douglas
TitleDirector
CompanyJazz Pharmaceuticals plc
TickerJAZZ
Transaction TypeSale
Transaction Date2026-06-15
Shares Traded1,157
Price Per Share$230.55
Total Value$267K
Filed Date2026-06-17
Accession Number0001756253-26-000004

Ownership Context

Shares Owned After Transaction9,680
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001756253-26-000004

Other Insider Trades — JAZZ

Other Trades by Smith Mark Douglas

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for JAZZ — Jazz Pharmaceuticals plc →

Track JAZZ insider activity in real time on The Wire →

Get alerts when Smith Mark Douglas files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:00 UTC

Want real-time data? Access The Wire for live sentiment tracking.